Skip to content
healthcare.dev

Uceris

NDC 68012-309, budesonide, tablet, extended release, from Santarus Inc..

Product NDC
68012-309
Status
Listed
Labeler
Santarus Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA203634
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68012-309 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUDESONIDE9 mg/1

Pharmacologic classes

Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]

Package NDCNDC-11Package
68012-309-01680120309012 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (68012-309-01)
68012-309-02680120309022 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (68012-309-02)
68012-309-306801203093030 TABLET, EXTENDED RELEASE in 1 BOTTLE (68012-309-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/92cbb190-8851-46ed-bfe0-166ca62ef2e9

Use it

Look up 68012-309 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68012-309 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68012-309. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.